NHC Stock Analysis: Buy, Sell, or Hold?
NHC - National Healthcare Corp.
$203.41
2.01 (1.00%)
▲
5d:
+4.0%
30d:
+3.78%
90d:
+25.76%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When NHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NHC shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: NHC shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NHC is currently trading at $203.41, which is considered extended relative to its 30-day fair value range of $186.75 to $198.51.
Technical Outlook: Technically, NHC is in a strong uptrend. The price is approaching resistance at $195.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $6.15. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NHC is in a strong uptrend. The price is approaching resistance at $195.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $6.15. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$186.75 -
$198.51
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 96.9% above Wall St target ($6.15)
Trading Range Analysis
30-Day Trading Range
$186.75 -
$198.51
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.81
(3.8%)
Support & Resistance Levels
Support Level
$176.75
Resistance Level
$195.90
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.89
Wall Street Target
$6.15
(-96.9%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
9.7%
Profit Margin
8.1%
Share & Embed Analysis
Last updated: June 23, 2026 12:57 PM ET
Data refreshes hourly during market hours. Next update: 1:57 PM
Data refreshes hourly during market hours. Next update: 1:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
